Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
Go back to Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition| Medtronic Inc. (NYSE: MDT) | Delayed: 92.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.60 | 52 Week High | $89.27 | |||
| Open | $92.60 | 52 Week Low | $71.03 | |||
| Day High | $92.60 | P/E | 26.31 | |||
| Day Low | $92.60 | EPS | $3.52 | |||
| Volume | 3,432 | |||||
